$VCEL News

TD Cowen Maintains Buy on Vericel, Raises Price Target to $58

Truist Securities Reiterates Buy on Vericel, Raises Price Target to $58

Vericel Corporation 2026 Q2 - Results - Earnings Call Presentation

HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $72

Vericel (NASDAQ:VCEL) Beats Q2 Estimates, Raises Guidance, Shares Rise

Vericel Corporation (VCEL) Q2 2026 Earnings Call Transcript

Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate

Vericel Raises FY2026 Sales Guidance from $326.000M-$336.000M to $330.000M-$340.000M vs $332.199M Est

HC Wainwright & Co. Reiterates Buy on Vericel, Maintains $70 Price Target

Vericel Corp (NASDAQ:VCEL): Strong Growth Stock With a Bull Flag Breakout Setup

Vericel Corp (NASDAQ:VCEL): An Affordable Growth Stock at a Reasonable Valuation

Truist Securities Maintains Buy on Vericel, Raises Price Target to $54

Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests

Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech

Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout

Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026

Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen

Vericel Corporation 2026 Q1 - Results - Earnings Call Presentation

Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report

Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth